CDKN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.064000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.517600E-01
Normal-vs-Stage2
1.925810E-01
Normal-vs-Stage3
3.006800E-01
Normal-vs-Stage4
5.126000E-01
Stage1-vs-Stage2
2.288000E-01
Stage1-vs-Stage3
7.577200E-01
Stage1-vs-Stage4
8.801000E-01
Stage2-vs-Stage3
4.621000E-01
Stage2-vs-Stage4
3.981400E-01
Stage3-vs-Stage4
9.061000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.055200E-01
Normal-vs-AfricanAmerican
3.471400E-01
Normal-vs-Asian
8.733700E-02
Caucasian-vs-AfricanAmerican
3.278400E-01
Caucasian-vs-Asian
2.070400E-01
AfricanAmerican-vs-Asian
4.402200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.513760E-01
Normal-vs-Female
2.586400E-01
Male-vs-Female
6.011200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.597600E-01
Normal-vs-Age(41-60Yrs)
2.301200E-01
Normal-vs-Age(61-80Yrs)
1.674150E-01
Normal-vs-Age(81-100Yrs)
1.826170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.084600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.814000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.810000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.373430E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.576400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.086000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.103600E-01
Normal-vs-Daily Drinker
1.179570E-01
Normal-vs-Weekly Drinker
9.677900E-02
Normal-vs-Occasional Drinker
2.157600E-01
Normal-vs-Social Drinker
1.573850E-01
Non Drinker-vs-Daily Drinker
6.296000E-01
Non Drinker-vs-Weekly Drinker
4.685000E-01
Non Drinker-vs-Occasional Drinker
4.681000E-01
Non Drinker-vs-Social Drinker
9.015000E-01
Daily Drinker-vs-Weekly Drinker
5.834800E-01
Daily Drinker-vs-Occasional Drinker
7.462000E-01
Daily Drinker-vs-Social Drinker
7.584200E-01
Weekly Drinker-vs-Occasional Drinker
7.074600E-01
Weekly Drinker-vs-Social Drinker
5.064800E-01
Occasional Drinker-vs-Social Drinker
6.038400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.679400E-01
Normal-vs-Grade 2
6.064400E-01
Normal-vs-Grade 3
6.149200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.380200E-02
Grade 1-vs-Grade 3
6.220500E-03
Grade 1-vs-Grade 4
5.679400E-01
Grade 2-vs-Grade 3
5.873400E-01
Grade 2-vs-Grade 4
6.064400E-01
Grade 3-vs-Grade 4
6.149200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.020000E-01
Normal-vs-NonDiabetic
2.343400E-01
Diabetic-vs-NonDiabetic
4.054600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.049800E-02
Normal-vs-NoPancreatitis
2.399600E-01
Pancreatitis-vs-NoPancreatitis
4.172600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.646400E-02
Normal-vs-N1
2.159000E-01
N0-vs-N1
1.793570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.767080E-04
Normal-vs-TP53-NonMutant
2.217200E-01
TP53-Mutant-vs-TP53-NonMutant
6.22619999999241E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
